Phosphoinositide 3-kinase inhibitor

Alpelisib - Taselisib

TrialStudied treatmentControl treatmentpatientsROBResultNCT

advanced breast cancer (metastatic)

alpelisib
SOLAR-1 ongoing alpelisib + fulvestrantfulvestrant alone - NCT02437318
taselisib
SANDPIPER, 2018taselisib + fulvestrantfulvestrant alone2L ER PIK3CA-MUT - NCT02340221